Sarepta Therapeutics Inc Sustainability Reports
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics, gene therapy, and editing links for the treatment of rare genetic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300IKDPIED8J8IG21
FIGI: BBG001S6KJC6
6 reports from 2013 to 2025